Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen to Help HUPO Design Proteomics Standards and Education Initiatives

NEW YORK (GenomeWeb News) - Invitrogen will help the Human Proteome Organization devise proteomic education initiatives, develop product advancements, and standardize research protocols, the groups said yesterday.
Terms of the deal call for Invitrogen and HUPO to work with proteomic laboratories to foster industry standards to enable large-scale data generation and analysis.
These standards will be disseminated through HUPO's Education and Training Initiative, which offers programs to promote expertise in all areas of proteomics including sample preparation, protein separation, mass spectrometry, bioinformatics, and experimental design.

"This is a great opportunity for HUPO and all its members to acquire and set standards that will become applicable world-wide," HUPO President John Bergeron said in a statement. "This standardization effort, which is one of several that HUPO is spear-heading, is a major part of our organization's mission, and will act as a major impetus to the implementation of world-wide proteomic standards."

Invitrogen offers a number of products for proteomic applications. The company sells its Zoom Benchtop fractionation and electrophoresis products, its Silac mass spectrometry reagents, as well as its ProtoArray protein microarrays, to those working in the area.

Financial terms of the collaboration were not disclosed.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.